EPSOLAY

Peak

benzoyl peroxide

NDATOPICALCREAM

Approved

Apr 2022

Lifecycle

Peak

Competitive Pressure

0/100

Clinical Trials

Mechanism of Action

12.1 Mechanism of Action Benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic effects but the precise mechanism of action in the treatment of rosacea is unknown. 12.2 Pharmacodynamics The pharmacodynamics of EPSOLAY in the treatment of rosacea are unknown. 12.3 Pharmacokinetics…

Indications (1)

inflammatory lesions of rosacea in adults

Clinical Trials (5)

NCT07205107N/ARecruiting

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

Started Oct 2025

200 enrolled

Acne Vulgaris

NCT03122457Phase 2Completed

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

Started Jan 2017

22 enrolled

Actinic Keratosis

NCT02058628Phase 4Completed

Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

Started Feb 2014

222 enrolled

Acne Vulgaris

NCT02052752Phase 4Completed

A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

Started Feb 2014

90 enrolled

Skin Diseases

NCT01446237N/ACompleted

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Started Jun 2011

125 enrolled

Acne Vulgaris